103 related articles for article (PubMed ID: 23221892)
41. Riboflavin and ultraviolet a collagen crosslinking of the cornea for the treatment of keratitis.
Morén H; Malmsjö M; Mortensen J; Ohrström A
Cornea; 2010 Jan; 29(1):102-4. PubMed ID: 19730094
[TBL] [Abstract][Full Text] [Related]
42. Pediatric ocular surface infections: a 5-year review of demographics, clinical features, risk factors, microbiological results, and treatment.
Wong VW; Lai TY; Chi SC; Lam DS
Cornea; 2011 Sep; 30(9):995-1002. PubMed ID: 21705879
[TBL] [Abstract][Full Text] [Related]
43. Photoactivated riboflavin treatment of infectious keratitis using collagen cross-linking technology.
Price MO; Tenkman LR; Schrier A; Fairchild KM; Trokel SL; Price FW
J Refract Surg; 2012 Oct; 28(10):706-13. PubMed ID: 23062001
[TBL] [Abstract][Full Text] [Related]
44. [Clinical, microbiological and therapeutic features of severe bacterial keratitis].
Darugar A; Gaujoux T; Goldschmidt P; Chaumeil C; Laroche L; Borderie V
J Fr Ophtalmol; 2011 Jun; 34(6):362-8. PubMed ID: 21507512
[TBL] [Abstract][Full Text] [Related]
45. [Antimicrobial agents in eye infections].
Polak BC
Ned Tijdschr Geneeskd; 1988 Sep; 132(38):1731-5. PubMed ID: 3173564
[No Abstract] [Full Text] [Related]
46. Microbiological and clinical profiles of patients with microbial keratitis residing in nursing homes.
Jhanji V; Constantinou M; Taylor HR; Vajpayee RB
Br J Ophthalmol; 2009 Dec; 93(12):1639-42. PubMed ID: 19574240
[TBL] [Abstract][Full Text] [Related]
47. Antimicrobial photodynamic therapy for treatment of biofilm-based infections.
Biel MA
Adv Exp Med Biol; 2015; 831():119-36. PubMed ID: 25384666
[No Abstract] [Full Text] [Related]
48. Infectious complications of solid organ transplantation.
Poghosyan T; Ackerman SJ; Ravenel JG
Semin Roentgenol; 2007 Jan; 42(1):11-22. PubMed ID: 17174171
[No Abstract] [Full Text] [Related]
49. [Evolution of ocular infection in diabetes mellitus patients].
Ignat F; Mocanu C
Oftalmologia; 2001; 53(3):74-7. PubMed ID: 11915696
[TBL] [Abstract][Full Text] [Related]
50. [Therapeutic strategies for non-infectious inflammatory diseases of the eye - when should which systemic therapy be initiated?].
Heinz C; Heiligenhaus A; Becker M
Klin Monbl Augenheilkd; 2010 Jun; 227(6):R79-90; quiz R91-2. PubMed ID: 20560096
[No Abstract] [Full Text] [Related]
51. [Perioperative management of chronic treatment and medical devices: anti-infectious, immunosuppressive].
Société francaise d'anesthésie et de réanimation
Ann Fr Anesth Reanim; 2009 Dec; 28(12):1057-65. PubMed ID: 20020552
[No Abstract] [Full Text] [Related]
52. Comment on: Rose Bengal Photodynamic Antimicrobial Therapy for Patients With Progressive Infectious Keratitis: A Pilot Clinical Study.
Nagpal R; Maharana PK; Sharma N
Am J Ophthalmol; 2020 Jun; 214():197-198. PubMed ID: 32331710
[No Abstract] [Full Text] [Related]
53. Reply to Comment on: Rose Bengal Photodynamic Antimicrobial Therapy for Patients With Progressive Infectious Keratitis: A Pilot Clinical Study.
Naranjo A; Arboleda A; Martinez JD; Durkee H; Aguilar MC; Relhan N; Nikpoor N; Galor A; Dubovy SR; Flynn HW; Miller D; Parel JM; Amescua G; Leblanc R
Am J Ophthalmol; 2020 Jun; 214():198-200. PubMed ID: 32276724
[No Abstract] [Full Text] [Related]
54. Infectious ophthalmology, a neglected field in clinical microbiology.
Drancourt M
Clin Microbiol Infect; 2013 Mar; 19(3):209. PubMed ID: 23438027
[No Abstract] [Full Text] [Related]
55. Keratitis solaris after long exposure to photoflood spotlights.
McLean C; Casey JH
Lancet; 1994 Nov; 344(8932):1301-2. PubMed ID: 7968013
[No Abstract] [Full Text] [Related]
56. Interactions between anti-infective agents and immunosuppressants in solid organ transplantation.
Trofe-Clark J; Lemonovich TL;
Am J Transplant; 2013 Mar; 13 Suppl 4():318-26. PubMed ID: 23465024
[No Abstract] [Full Text] [Related]
57. Introduction to Antimicrobial therapeutics reviews: infectious diseases of current and emerging concern.
Bush K
Ann N Y Acad Sci; 2014 Sep; 1323():v-vi. PubMed ID: 25195941
[No Abstract] [Full Text] [Related]
58. Ocular manifestation of systemic infections.
Madu AA; Mayers M
Curr Opin Ophthalmol; 1996 Dec; 7(6):85-90. PubMed ID: 10166559
[TBL] [Abstract][Full Text] [Related]
59. Contribution of complement to defensin action in eye.
Prohászka Z; Füst G
Lancet; 1998 Oct; 352(9134):1152. PubMed ID: 9798625
[No Abstract] [Full Text] [Related]
60. [Une flambée d'infections oculaires en pleine pandémie de COVID-19 : une réalité ou une coïncidence ?].
Khalili MR; Jahanbani-Ardakani H
J Fr Ophtalmol; 2021 Feb; 44(2):143-144. PubMed ID: 33431191
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
